Advertisement
YOU ARE HERE: LAT HomeCollectionsNational Cancer Institute
IN THE NEWS

National Cancer Institute

NEWS
May 8, 1987
A controversial drug to treat two lethal types of cancer has won approval from the Food and Drug Administration for wider trials in humans, it was announced. An FDA spokeswoman said the agency will permit the National Cancer Institute to expand the use of interleukin-2 to a larger number of patients with advanced melanoma and kidney cancer. The treatment will be available to patients selected for participation in tests at NCI-approved cancer centers.
Advertisement
NEWS
March 27, 1991 | From Times Staff and Wire Reports
Frying, broiling and barbecuing produce potentially carcinogenic compounds in meat, chicken and fish, but microwaving, stewing and poaching do not, the National Cancer Institute said in reporting on a laboratory study. Researchers at the institute's Division of Cancer Etiology found that cooking at high temperatures and for a long time produced compounds that caused cancer in monkeys and other lab animals. Dr.
NEWS
January 10, 2013 | By Rosie Mestel
Between 1940 and 1971, many pregnant women were treated with a synthetic estrogen, diethylstilbestrol -- commonly known as DES -- to prevent miscarriage and other complications. The drug didn't work for that purpose, but it did have biological effects on the women who took it,  as well as their children. On Wednesday, four sisters who'd been exposed to DES in the womb reached a settlement with one of the drug's principal makers, Eli Lilly & Co., during a federal trial in Boston, the Associated Press reported.
BUSINESS
February 8, 2012
A panel of cancer experts voted against a new use for Amgen Inc.'s Xgeva in prostate cancer on Wednesday, saying the drug's ability to slow the spread of the disease did not translate into meaningful benefits for patients. The Food and Drug Administration's cancer drug panel voted 12 to 1 that the benefits of the drug did not outweigh its risks, which included bone disease in about 6% of patients. The FDA is not required to follow the group's advice, although it often does. Xgeva is already approved to prevent fractures in cancerous bones, and for osteoporosis, in a different formulation called Prolia.
NEWS
August 6, 2010
The headlines were certainly scary enough to turn readers into vegetarians: "Sausages and Bacon Up Bladder Cancer Risk" "My Bologna Has a First Name, It's C-A-N-C-E-R. " "Cold Cut Sandwiches: A Potentially Deadly Lunch. " Fortunately for meat eaters out there, the study that prompted this week's dire warnings wasn't quite as absolute as it was made to appear. For starters, studies linking red meat consumption to cancer aren't new. But this study, published online Monday by the journal Cancer, zeroed in on a specific culprit -- processed red meat -- and a particular body part -- the bladder.
NEWS
February 28, 1989 | From United Press International
The federal government and the American Cancer Society on Monday announced a stop-smoking drive expected to reach more than one-fifth of the U.S. population and at least 15 million smokers. The National Cancer Institute estimates it will spend $116.5 million on the project, which is being billed as "the world's largest" effort to reduce smoking.
Los Angeles Times Articles
|